Compliance, quality of life and quantitative voice quality aspects of hands-free speech.
CONCLUSIONS
With the use of a new automatic stoma valve (ASV) it appears possible to rehabilitate patients who have previously been unsuccessful in acquiring hands-free speech. As well as making daily ASV use possible for an additional group of patients, this new device was also appreciated by many patients as an additional rehabilitation tool for specific occasions. Despite statistically significant improvements in aspects of voice and breathing using this novel ASV, improvement of peristomal adhesion is probably the main factor needed to further increase success rates. Nevertheless, our results show that it makes sense to keep trying to achieve hands-free speech, even if previous attempts have failed.


OBJECTIVE
To make a long-term (6 months) assessment of compliance and aspects of voice, breathing and quality of life using a new ASV: the Provox FreeHands heat and moisture exchanger (HME).


METHODS
This was a prospective clinical multicentre trial in 79 laryngectomized patients (8 regular ASV users, 58 previously unsuccessful users and 13 new users). Data were collected at baseline and after 1 and 6 months by means of European Organization for Research and Treatment of Cancer Quality of Life questionnaires and specific structured questionnaires concerning compliance, skin adhesion, voicing and pulmonary aspects. An objective assessment of voice parameters (maximum phonation time, maximum phonation time while counting, dynamic loudness range and number of pauses in a standard read-aloud text) was made for comparison of different stoma occlusion methods (digital occlusion via an HME and two different ASVs). A subjective assessment of overall voice quality was made.


RESULTS
After 6 months, 19% of patients used the new ASV on a daily basis (mean 5 h/day), while 57% used it on an irregular basis as an additional rehabilitation tool for special occasions. Two-thirds of the study group indicated that they would continue to use the new ASV after the study period. With respect to the objective parameters, statistically significantly better maximum phonation times and dynamic loudness ranges were observed with the new ASV compared to the Blom-Singer ASV. However, the best results for all the objective parameters were obtained with digital occlusion via the Provox HME.
Op de Coul
B M R
BM
Department of Otolaryngology, Head and Neck Surgery, University Medical Centre St Radboud, Nijmegen, The Netherlands.
Ackerstaff
A H
AH
van As-Brooks
C J
CJ
van den Hoogen
F J A
FJ
Meeuwis
C A
CA
Manni
J J
JJ
Hilgers
F J M
FJ
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007825:Laryngectomy; D007831:Larynx, Artificial; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010699:Phonation / Q000502:physiology; D011446:Prospective Studies; D011474:Prosthesis Design; D017755:Prosthesis Fitting; D011788:Quality of Life; D012119:Respiration; D013071:Speech, Alaryngeal / Q000295:instrumentation* / Q000379:methods; D013072:Speech, Esophageal / Q000379:methods; D013997:Time Factors; D014831:Voice / Q000502:physiology; D014833:Voice Quality